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Abstract
Many reports or manuals had focused on the implementation of iodine deficiency 
disorder (IDD) elimination programme from the point of view of the programme 
managers. In this chapter, we will focus on the importance of urinary iodine testing, 
its related diagnosis and further biomarker testing suggested for further diagnosis 
related to thyroid health. This chapter will be relevant for the respondents to the 
monitoring programme, particularly the 8–10-year-old schoolchildren and pregnant 
women, i.e., the vulnerable targeted groups from either the iodine-deficient areas 
or the Universal Salt Iodization (USI) gazetted areas. USI has been proposed by the 
World Health Organization (WHO) as the most cost-effective programme to elimi-
nate IDD, and it is also a way to increase the intelligent quotient (IQ ) of the world 
population for the future. This chapter had been laid out so that the readers will know 
briefly the rationale behind the testing of urinary iodine among schoolchildren and 
pregnant women under the implementation of the USI programmes in their countries 
and their benefits, especially the utilisation of urinary iodine as the biomarker to por-
tray the population iodine status. Diagnosis including iodine-induced thyroid diseases 
and further biomarkers measurement besides urinary iodine is also discussed briefly.
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1. Introduction
1.1 Importance of urinary iodine testing to determine population iodine nutrition
All iodine in the blood is in the iodide form either it is taken up by the thyroid 
and converted into thyroid hormone or being excreted in the urine. Almost 90% of 
the ingested iodine is excreted in the urine. Therefore, urinary iodine excretion is 
a good biomarker of very recent dietary iodine intake [1]. On an individual basis, 
24-hour urine sample is necessary for the assessment of iodine intake as the level is 
more consistent in iodine-deficient populations than in those with adequate iodine 
intake (Figure 1). On a population basis, the median urinary iodine concentration 
(mUIC) of spot urine from sufficiently large randomly selected 8–10-year-old chil-
dren or adults has been shown to provide useful information on the average iodine 
intake or status of a community. On an individual basis, urinary iodine varies from 
day to day and even within a given day. However, this variation tends to even out 
among population [2]. Most of the epidemiological IDD studies had emphasised on 
rapid inexpensive methods of urinary iodine determination that could be applied to 
a large number of samples [3].
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The main biochemical indicator that is widely used for the assessment of IDD 
is urinary iodine concentration (mUIC) [4]. The advantages of mUIC as an indica-
tor of IDD are that the method directly reflects iodine supply of the individual, 
it is objective and non-invasive and urine samples can be kept for later analysis. 
However, the disadvantages of this method are that it requires laboratory space, 
special facilities and skilled technician to provide accurate determinations. In addi-
tion, this method reflects only current but not past intake of iodine [5].
Epidemiological studies stated that the population distribution of urinary iodine 
is required rather than individual levels. The frequency distribution of urinary 
iodine usually skewed towards elevated values; hence, the median value is consid-
ered instead of the mean as indicating the status of iodine nutrition [1]. The mUIC 
of 100 μg/L and above defines a population which has no IDD; i.e. at least 50% of 
the sample should be >100 ug/L. In addition, not more than 20% of sample should 
be below 50 μg/L. Iodine nutrition status is based on six categories of urinary excre-
tion classification (Table 1) [3].
Median urinary iodine concentration (μg/L) Severity of IDD
<20 Severe deficient
20–49 Moderate deficient
50–99 Mild deficient
100–199 Optimal
200–299 More than adequate
>300 Excessive
Source: Ref. [3].
Table 1. 
Epidemiological criteria for assessing IDD in a population based on median urinary iodine concentration.
Figure 1. 
Degrees of iodine intake (iodine nutrition status) and their suitable types of human sample collection to 
determine the median urinary iodine concentration (mUIC).
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1.2 Iodine role in thyroid hormone synthesis and its contribution to human body
1.2.1 Thyroid hormone synthesis
Iodine is grouped under micronutrients, and it is needed in small amount, 
but it is very important for the development of optimum human growth. Iodine 
is needed in the synthesis of thyroid hormones [6]. Through iodination, one, 
two, three or four iodine atoms are bound to tyrosine to form monoiodothy-
ronine (MIT), diiodothyronine (DIT), triiodothyronine (T3) or thyroxine 
(T4), respectively, through the action of iodinase enzyme. Iodine is absorbed 
from the gastrointestinal system, will enter the blood circulation and will be 
transported into the thyroid follicle cells through the sodium/iodine (Na/I) 
symporter. In iodide form, it will then be transported to the thyroid follicle 
colloid through pendrin. Concurrently, thyroglobulin (TG) is being synthesised 
in the endoplasmic reticulum (ER) and being secreted into the follicle colloid 
through exocytosis. TG is the transporter protein of the thyroid hormones in 
the thyroid follicle colloid. It consists of branches of tyrosine molecules which 
will then be bound to iodine through the iodination process, forming the MIT 
and the DIT. When one MIT and one DIT bind, T3 will be formed, while upon 
binding of two DITs, T4 will then be formed. These TG-bound thyroid hormones 
will enter the thyroid follicular cell through endocytosis. TG will then undergo 
proteolysis, and T3 and T4 will be transported into the blood circulation through 
the MCT symporter [7] (Figure 2).
1.2.2 Iodine’s contribution to human body
Iodine is a micronutrient which is present in the body in minute amount. The 
quantity of iodine required by an individual is about 150–200 μg/day [8]. Its 
main role is in the synthesis of thyroid hormone which is essential for the brain 
Figure 2. 
Thyroid hormone synthesis in the thyroid gland (image reproduced with permission from the rights holder, 
Journal of Thyroid Research) [13].
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and physical development [9]. The regulation of thyroid hormones is under the 
control of the pituitary gland through thyroid-stimulating hormone (TSH). TSH 
secretion is regulated by a ‘feedback’ mechanism related to the level of thyroid 
hormones thyroxine [3,5,3′,5′-tetraiodothyronine (T4)] in the blood. Iodine is 
needed in the human body, and as the blood T4 falls, the pituitary TSH secretion 
is increased. In severe iodine deficiency disorders (IDD), the level of T4 remains 
lowered, and the level of TSH remains elevated. Both these measurements are 
used for diagnosis of hypothyroidism due to IDD at various stages in life particu-
larly in neonates [10].
2. Iodine deficiency disorders (IDD) and symptoms
2.1 Causes of IDD
Most of the iodine exists in the ocean and seafood, including saltwater fish, 
shellfish, kelp, seaweed and seaweed products which can provide a considerable 
amount of iodine [11]. Iodine exists in the sea and the soil as iodide. Iodide ions 
are oxidised by sunlight to elemental iodine which is volatile. The iodine cycle 
in nature is complete if the concentration of iodide in the seawater is about 
50–60 μg/L, approximately 0.7 μg/m3 in the air, and the iodine in the atmo-
sphere is returned to the soil through rain, with concentrations in the range of 
1.8–8.5 μg/L. Iodine deficiency occurs in the soil when the return of the iodine 
to the soil is slow and in small amount compared to the original loss of iodine. 
Hence, all crops grown in this soil will be iodine deficient [12]. Low levels of 
iodine in the diet for people who do not get enough iodine from their food may 
lead to health problems collectively referred to as iodine deficiency disorders 
(IDD) [14].
2.2 The problem of IDD to human population
IDD is a major public health problem for population throughout the world 
which affects human from early foetal life through to adulthood [15]. Although 
IDD can affect any person of any age, pregnant women and children are the 
most vulnerable high-risk group for IDD [16]. Iodine requirement is high dur-
ing pregnancy; it may increase by 50% because of increased maternal thyroxine 
production [14].
IDD in the foetus is the result of IDD in the mother, and this condition is 
associated with greater incidence of stillbirths, abortions, congenital abnormalities, 
neurological cretinism and psychomotor defects (Figure 3). In neonate, apart from 
mortality, the continuing severe IDD may affect the brain and physical develop-
ment. Low birth weight is normally associated with a higher rate of congenital 
anomalies, and there were also evidences on substantial fall in infant mortality with 
improved birth weight following the iodized oil injection. IDD in the child and ado-
lescent is associated with juvenile hypothyroidism, impaired mental function and 
retarded physical development. Studies on schoolchildren living in iodine-deficient 
areas indicated impaired school performance and IQs [17], while IDD in the adult 
had effects on their individual capacity, initiative and decision-making (Figure 3). 
These results indicate that IDD can be a major obstacle to human and social devel-
opment of population living in an iodine-deficient environment. Therefore,  
correction of iodine deficiency is considered as a major contribution to population 
development [18].
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3. Iodine needs in pregnant women and their foetuses
Pregnant woman is one of the most susceptible groups for iodine deficiency. 
An adequate intake of iodine in the diet of pregnant woman is important to ensure 
normal growth and development of the foetus. During pregnancy, iodine requirement 
increases substantially to ensure adequate supply to the foetus particularly for healthy 
brain development. Iodine deficiency during pregnancy can cause maternal and foetal 
hypothyroidism and impairs neurological development of the foetus since it is second-
ary to transplacental passage of iodide. The consequences depend upon the timing and 
severity of hypothyroidism; the most severe manifestation is cretinism [14].
Since most foods have relatively low iodine content, Universal Salt Iodization 
(USI) programmes are executed. However, in countries or setting where USI is not 
possible, other mode of iodine supplementation needs to be implemented. It is difficult 
to accurately quantify iodine intakes using traditional methods of dietary assessment 
in terms of the contribution of iodized salt use from table and cooking to total iodine 
intake. In view of the limitations of dietary assessment for adequate iodine, a mUIC 
Figure 3. 
Effect of iodine deficiency and the spectrum of IDD across the life span (clinical presentation) in various age groups, 
i.e. foetus, neonate, infant, child, adolescent and adult.
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of 150–249 μg/L has been established to determine the adequate iodine status among 
pregnant women. However, the large intra-individual variation in UIC  
from either spot or 24-hour urine samples means that UIC cannot be used to assess 
iodine status in an individual pregnant woman. Therefore, the association between iodine 
status in pregnancy and the developmental outcome of the individual child is rather 
difficult to be assessed.
4.  IDD elimination programme worldwide and Universal Salt Iodization 
(USI) programme
Universal Salt Iodization (USI) is currently the most widely used strategy 
towards sustainable control and elimination of IDD. There was a significant prog-
ress since the adoption of USI as a primary strategy to address IDD in 1993. Iodizing 
table salt is one of the best and least expensive methods of preventing IDD. Salt 
is used as a key vehicle as it is widely available and consumed in a regular amount 
throughout the year apart from a very low cost of salt iodization with US$ 0.05 per 
person per year [1]. This strategy has been implemented in most countries where 
iodine deficiency is a public health problem.
Various concerted global efforts have also been undertaken to eliminate IDD. This 
includes extensive advocacy from the international partners/alliances such as 
the WHO, UNICEF and ICCIDD (International Council for Control of Iodine 
Deficiency Disorders). These alliances have been in the forefront in helping coun-
tries to set up national salt iodization programmes. As reported by WHO/UNCEF/
ICCIDD, there are currently 65 countries worldwide implementing USI as an effec-
tive strategy to eliminate IDD [3]. However, an effective USI in correcting iodine 
deficiency adequately through iodized salt must reach the whole affected population 
including pregnant women and children. Therefore, close and regular monitoring of 
iodized salt at various levels from the production, importation, retailer and house-
hold is crucial. Such monitoring requires close collaboration between the govern-
ments, salt industries and importers. In countries or areas within countries where 
USI is not possible, iodine supplementation needs to be implemented and especially 
targeted to pregnant women and children until USI is scaled up.
5. Urinary iodine results and their implications
Upon consumption, the needed amount of iodine is retained in the body, while 
excess iodine is excreted. Thus, high urinary iodine concentration does not reflect 
a disease state yet, but if persists on repeated urine sample, further blood tests is 
recommended. Urinary iodine reflects the food consumption taken overnight, and 
it is just an immediate biomarker (short-term reflection) for iodine intake. Thus, the 
long-term reflection of iodine intake will be more representative by measuring blood 
thyroglobulin (TG) as it is synthesised parallel to the amount of iodine present in the 
thyroid follicular cells. The very low or high individual urinary iodine readings will 
usually be repeated for testing to ensure that it is replicating the first reading.
6.  Other blood biomarker measurement to support iodine-deficient 
status determined through urinary iodine measurement
For respondents with high mUIC, other biomarkers such as blood thyroglobulin 
(TG), thyroid-stimulating hormone (TSH), thyroid hormones (free thyroxine, fT4; 
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free triiodothyronine, fT3) and thyroid antibodies, thyroid peroxidase antibodies 
(TPO Ab) and thyroglobulin antibodies (TgAb) are thus suggested for further 
diagnosis. Brief information on these biomarkers is as stated below:
6.1 Free thyroxine (fT4) and free triiodothyronine (fT3)
T4 is a molecule of thyronine bond to four atoms of iodine, while T3 has three 
iodine atoms. T4 is more abundant than T3, but through deiodinase activity, the more 
potent T3 is synthesised. Low level of T4 usually indicates hypothyroidism. For clini-
cal biochemistry free T4 (fT4) and free T3 (fT3) are usually measured as these are the 
biologically active forms. Reference intervals for fT4 and fT3 are as stated in Table 2.
6.2 Thyroid-stimulating hormone (TSH)
TSH is released upon the induction by thyrotropin-releasing hormone (TRH), 
secreted from the hypothalamus. TRH is secreted when serum T3 and/or T4 is low. 
TSH induces the production of thyroid hormones T3 and T4. Low level of TSH 
usually indicates hyperthyroidism (parallel to high levels of T3 and/or T4) [17]. 
Reference interval for TSH is as stated in Table 2.
6.3 Thyroglobulin (TG)
TG is the globulin where binding of iodine to tyrosine to form thyroid hormones 
takes place. It is the long-term biomarker for iodine status in a human, besides 
urinary iodine as the short-term biomarker for iodine nutrition.
The median for reference interval for dried blood spot (DBS) TG from 5- to 
14-year-old children before intervention of iodized salt is 49 g/L. After using 
iodized salt for 5 months, the DBS-TG decreased to 13 g/L and further decreases to 
8 g/L after 10 months of consumption of iodized salt [20].
6.4  Thyroid antibodies [thyroid peroxidase antibodies (TPO Ab) and 
thyroglobulin antibodies (TgAb)]
This antibody is for binding to the antigen thyroid peroxidase (TPO) enzyme 
which is responsible for thyroid hormones synthesis. Once the enzyme is bound 
to the antibody, less free unbound enzymes are available for thyroid hormone 
Whole group (n = 870) Constraint group (n = 453)
Hormone Median Minimum-
Maximum
2.5th–97.5th 
percentilesa
Median Minimum-
Maximum
2.5th–97.5th 
percentilesa
TSH, mIU/L 1.31 0.05–14.50 0.30–3.63 1.36 0.12–5.29 0.40–3.77b
T4, nmol/L 101.00 52.10–209.00 71.50–158.00 98.30 61.80–173.00 70.50–157.00
T3, nmol/L 1.77 0.89–4.00 1.23–2.80 1.77 0.89–3.96 1.27–2.79
FT4, pmol/L 16.20 8.24–28.60 12.70–20.80 16.20 9.30–24.70 12.80–20.40
FT3, pmol/L 5.10 2.52–9.96 3.89–6.66 5.13 2.52–9.96 4.02–6.79
aData are reported as empirical percentiles.
bThe lower limit of the TSH reference interval in the constraint group was >5% different from the comparable limit 
of the whole group.
Table 2. 
Reference intervals for thyroid hormones from subjects with normal thyroid gland assessed sonographically 
(table reproduced with permission of the rights holder, Clinical Chemistry) [19].
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synthesis, thus causing lower thyroid hormone production. TgAb is the antibody for 
the globulin TG. With the presence of elevated amount of TgAb, the thyroglobulin 
(TG) will bind to its antibody, and lesser TG is available to bind to the thyroid hor-
mones for transportation in the blood vessels, thus causing lesser thyroid hormones 
being circulated in the human body [21]. The reference intervals are 15 kIU/L for 
TPOAb and 31 kIU/L for TgAb [22] (Figure 4).
7. Diagnosis for the iodine-induced thyroid dysfunction in respondents
Both insufficient and excessive iodine intake can result in thyroid dysfunctional 
diseases. If the thyroid diseases are due to iodine-induced phenomena, the main 
management is to avoid or reduce iodine intake, followed by the appropriate drugs 
if symptomatic or there is abnormality with the thyroid function test (TFT) results.
7.1 Iodine-induced hypothyroidism
Iodine-induced hypothyroidism can occur in normal individuals and in those 
with chronic systemic disease and underlying thyroid disorders. It has been seen in 
patients who had a history of post-partum thyroiditis and subacute thyroiditis and in 
those treated with recombinant interferon-alpha. The hypothyroidism was described 
as transient, and thyroid function returns to normal in 2–3 weeks after iodide with-
drawal. Some patients may require transient T4 replacement therapy [23].
7.1.1 Clinical presentation
The presenting clinical features of hypothyroidism depend on the duration and 
severity, the nature of its onset and the patient’s psychological characteristics [24]. 
The following are the signs and symptoms of hypothyroidism:
Figure 4. 
Subsequent biomarker testing and further action for individual and population urinary iodine estimation.
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• Fatigue
• Weight gain from fluid retention
• Dry skin and cold intolerance
• Yellow skin
• Coarseness or loss of hair
• Hoarseness
• Goitre
• Reflex delay, relaxation phase
• Ataxia
• Constipation
• Memory and mental impairment
• Decreased concentration
• Depression
• Irregular or heavy menses and infertility
• Myalgias
• Hyperlipidaemia
• Bradycardia and hypothermia
• Myxoedema fluid infiltration of tissues
7.1.2 Diagnosis
When there is clinical suspicion of hypothyroidism, a thyroid function test should 
be performed. Measurement of TSH level is the primary test to confirm primary hypo-
thyroidism. Other laboratory evaluation may include free T4 and thyroid antibodies 
(anti-thyroid peroxidase and anti-thyroglobulin autoantibodies). Imaging studies to 
evaluate any structural thyroid abnormalities include a thyroid scan, ultrasonography 
or both [24]. When iodine deficiency occurs during pregnancy, it is associated with 
foetal hypothyroidism, mental impairment and increased neonatal and infant mortal-
ity [25]. In adults, iodine-induced hypothyroidism is rare. The most common manifes-
tation is goitre. Low iodine intake leads to reduced T4 and T3 production which results 
in increased TSH secretion in an attempt to restore normal T4 and T3 production. TSH 
also stimulates thyroid growth leading to goitre. The goitre is initially diffuse but pro-
gresses to nodular goitre and eventually to thyroid autonomy and possible hyperthy-
roidism [26]. Excess iodine ingestion or exposure above the limit of the recommended 
daily iodine intake induces thyroid dysfunction. Iodine-induced thyroid dysfunction 
may be subclinical or overt. Excess iodine is generally well tolerated. However, 
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individuals with underlying thyroid disease or other risk factors may be susceptible to 
iodine-induced thyroid dysfunction following acute or chronic exposure.
7.1.2.1. Predisposing risk factors in iodine-induced hypothyroidism
Individuals with underlying thyroid disease:
a. Euthyroid Graves’ disease previously treated by radioactive iodine, thyroidectomy 
or anti-thyroid drugs
b. Hashimoto’s thyroiditis
c. Euthyroid with a history of subacute thyroiditis
d. Euthyroid with a history of post-partum thyroiditis
e. Euthyroid with a history of type 2 amiodarone-induced thyrotoxicosis
f. Euthyroid posthemithyroidectomy
g. Euthyroid after interferon-alpha therapy
The spectrum of iodine deficiency disorders (IDD) is seen across the life span in 
various age groups, i.e. foetus, neonate, infants, child, adolescent and adult. They 
include endemic goitre and cretinism, endemic mental retardation, decreased fertil-
ity rate, increased perinatal death and infant mortality and varying degrees of other 
growth and developmental abnormalities (Table 3) [27, 28]. Hypothyroidism due to 
very low iodine intake is now extremely rare. Adults usually have the typical clinical 
manifestations of hypothyroidism and goitres [29].
Life stage Spectrum of IDD
Foetus Abortions
Deaf mutism
Stillbirths
Congenital anomalies
Increased perinatal mortality
Endemic cretinism
Neonate Neonatal goitre
Neonatal hypothyroidism
Endemic mental retardation
Increased susceptibility of the thyroid gland to nuclear radiation
Child and adolescent Goitre
Subclinical hypothyroidism
Impaired mental retardation
Retarded physical development
Increased susceptibility of the thyroid gland to nuclear radiation
Adult Goitre with its complications
Hypothyroidism
Impaired mental function
Hyperthyroidism in the elderly (after iodized salt)
Source: Refs. [27, 28].
Table 3. 
The spectrum of IDD across the life span.
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7.2 Iodine-induced hyperthyroidism
Iodine-induced hyperthyroidism can occur after intake of excess iodine in 
the diet, exposure to radiographic contrast media for imaging procedures or 
medications [30]. In iodine-sufficient areas, iodine can induce hyperthyroid-
ism in euthyroid patients with previous thyroid diseases. These include patients 
who were treated with anti-thyroid drugs for Grave’s disease and post-partum 
 thyroiditis [31, 32].
7.2.1 Clinical presentation
The severity and spectrum of symptoms and signs of hyperthyroidism may be 
related to the duration of the illness, the effects of excess thyroid hormone and the 
age of the patient [24].
The symptoms and signs include the following:
• Nervousness and irritability
• Palpitations and tachycardia
• Heat intolerance or increased sweating
• Tremor
• Weight loss or gain
• Alterations in appetite
• Frequent bowel movements or diarrhoea
• Dependent lower-extremity oedema
• Sudden paralysis
• Exertional intolerance and dyspnoea
• Menstrual disturbance (decrease flow)
• Impaired fertility
• Mental disturbances
• Sleep disturbances (including insomnia)
• Changes in vision, photophobia, eye irritation, diplopia or exophthalmos
• Fatigue and muscle weakness
• Goitre (depending on cause)
• Pretibial myxoedema
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8. Novel strategies for the vulnerable group
In the Iodine Global Network newsletter published on its website,  
Prof. Dr. Zimmermann had laid out the strategies needed for the vulnerable groups, 
i.e., the newborns, infants and the children. He had suggested that these tests 
should be done on these groups respectively: blood thyroid-stimulating hormone, 
urinary iodine and blood spot thyroglobulin (http://www.ign.org/zimmermann-
calls-for-new-strategies-against-idd.htm). He also suggested using the TSH 
measurement in the newborn screening for iodine assessment. Commonly, iodine-
deficient newborns present with elevated TSH. The WHO reported that if the TSH 
level is greater than 5 mIU/L from the whole blood of 3% of the newborns measured 
after 3–4 days post-birth, this would indicate that the population is iodine deficient. 
Another suggestion made by him was to use the newborns’ urinary iodine as a 
marker of IDD in addition to the current practise of measuring the median urinary 
iodine of the schoolchildren. Using a non-invasive system, urine was collected from 
infants, and study had shown that in 1200 infants, the baseline TSH of 77 μg/L had 
increased to 100 μg/L after 4 days post-birth. In addition to that, a system for col-
lecting young children blood spot was done to measure their TG concentration, and a 
reference range of 4–40 μg/L had been determined. Noteworthy, there are challenges 
in order to establish a specific international reference range among newborns as there 
will be differences between the population from the USI areas and the non-USI areas.
9. Conclusion
Excess urinary iodine is generally well tolerated, but individuals with underlying 
thyroid disease or other risk factors may be susceptible to iodine-induced thyroid 
dysfunction following acute or chronic exposure. Increased iodine exposure includ-
ing the global public health efforts of iodine supplementation, the escalating use 
of iodinated contrast radiologic studies, amiodarone administration in vulnerable 
patients, excess seaweed consumption and various miscellaneous sources should be 
looked for.
Iodine-induced thyroid dysfunction may be subclinical or overt. Recognition 
of the association between iodine excess and iodine-induced hypothyroidism or 
hyperthyroidism is important in the differential diagnosis of patients who present 
without a known cause of thyroid dysfunction.
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